Discover
NAGE
Niagen Bioscience Inc
3.06
14 x 3.05
12 x 3.06
bid
ask
+
0.01
0.27%
12:36 PM
timesize
| Ytd | -51.92% | |
| 1y | -68.86% |
3.04
day range
3.08
2.87
52 week range
10.52
| Open | 3.05 | Prev Close | 3.05 | Low | 3.04 | High | 3.08 | Mkt Cap | 243.59M |
| Vol | 224.73K | Avg Vol | 814.17K | EPS | 0.16 | P/E | 19.12 | Forward P/E | N/A |
| Beta | 2.09 | Short Ratio | 3.35 | Inst. Own | 33.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 3.38 | 200-d Avg | 5.04 | 1yr Est | 14.90 |
| Income Statement | |||
| Total Revenue | 29.79M | ||
| Revenues (USD) | 29.79M | ||
| Cost of Revenue | 10.47M | ||
| Gross Profit | 19.31M | ||
| Operating Expenses | 18.61M | ||
| Research and Development Expense | 1.51M | ||
| Selling, General and Administrative Expense | 17.10M | ||
| Operating Income | 700.00K | ||
| Income Tax Expense | 106.00K | ||
| Net Income | 963.00K | ||
| Net Income Common Stock | 963.00K | ||
| Net Income Common Stock (USD) | 963.00K | ||
| Consolidated Income | 963.00K | ||
| Earnings per Basic Share | 0.01 | ||
| Earnings per Basic Share (USD) | 0.01 | ||
| Earnings per Diluted Share | 0.01 | ||
| Earning Before Interest & Taxes (EBIT) | 1.07M | ||
| Earning Before Interest & Taxes (USD) | 1.07M | ||
| Weighted Average Shares | 79.32M | ||
| Weighted Average Shares Diluted | 82.50M | ||
| Balance Sheet | |||
| Cash and Equivalents | 66.74M | ||
| Cash and Equivalents (USD) | 66.74M | ||
| Trade and Non-Trade Receivables | 8.58M | ||
| Current Assets | 97.79M | ||
| Property, Plant & Equipment Net | 3.09M | ||
| Total Assets | 106.59M | ||
| Debt Current | 917.00K | ||
| Total Debt | 2.33M | ||
| Current Liabilities | 15.05M | ||
| Debt Non-Current | 1.41M | ||
| Total Liabilities | 24.06M | ||
| Accumulated Retained Earnings (Deficit) | -157.25M | ||
| Accumulated Other Comprehensive Income | -2.00K | ||
| Shareholders Equity | 82.53M | ||
| Shareholders Equity (USD) | 82.53M | ||
| Assets Non-Current | 8.80M | ||
| Total Debt (USD) | 2.33M | ||
| Deferred Revenue | 2.43M | ||
| Deposit Liabilities | 329.00K | ||
| Goodwill and Intangible Assets | 5.31M | ||
| Inventory | 20.64M | ||
| Liabilities Non-Current | 9.01M | ||
| Trade and Non-Trade Payables | 9.44M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 470.00K | ||
| Net Cash Flow from Financing | -2.49M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 191.00K | ||
| Capital Expenditure | -89.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -3.00K | ||
| Issuance (Purchase) of Equity Shares | -2.49M | ||
| Net Cash Flow from Investing | -92.00K | ||
| Net Cash Flow from Operations | 2.77M | ||
| Share Based Compensation | 1.72M | ||